» Articles » PMID: 15864247

Patients with Heart Failure Who Die in Hospice

Overview
Journal Am Heart J
Date 2005 May 3
PMID 15864247
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients with end-stage heart failure experience disability, dyspnea, pain, and suffering at the end of life despite progress in treatment approaches. Little is known about the patients with heart failure in hospice and the impact of hospice care on health-related outcomes.

Methods And Results: The purposes of this retrospective, descriptive chart review were to (1) describe the characteristics of patients who receive hospice care, (2) identify symptoms most commonly reported by patients with heart failure in hospice during the last 7 days of life, and (3) identify interventions used by hospice nurses to manage the symptoms. The majority of the patients were women, widowed, and white. Median length of stay was 10 days. Nearly 37% of the patients were admitted to hospice during the last week of life. Primary symptoms at admission for hospice care included dyspnea, confusion at least some of the time, and poor appetite. There was no statistically significant difference in symptoms between the day of admission for hospice care and the day of death. Symptom management strategies included oxygen, family reassurance or education, skin care, and patient education. Medications commonly used to relieve symptoms included antianxiety medications, morphine, and/or other narcotics. Although mainstay heart failure drugs had been prescribed for some patients, prescription rates were low and not in line with current guideline recommendations, nor were those medications recorded as being used for symptom management.

Conclusion: Further research including prospective study is needed to clearly articulate the impact of hospice care on patients and families affected by heart failure.

Citing Articles

Palliative patients who may benefit from intranasal delivery of symptomatic drugs: a two-center observational study evaluated the administration of morphine and dexamethasone in Polish hospices.

Ingielewicz A, Brunka Z, Szczupak M, Szymczak R Support Care Cancer. 2025; 33(2):140.

PMID: 39893351 PMC: 11787208. DOI: 10.1007/s00520-025-09189-z.


Influence of depression and gender on symptom burden among patients with advanced heart failure: Insight from the pain assessment, incidence and nature in heart failure study.

Haedtke C, Moser D, Pressler S, Chung M, Wingate S, Goodlin S Heart Lung. 2019; 48(3):201-207.

PMID: 30879736 PMC: 7582916. DOI: 10.1016/j.hrtlng.2019.02.002.


Educate, Nurture, Advise, Before Life Ends Comprehensive Heartcare for Patients and Caregivers (ENABLE CHF-PC): study protocol for a randomized controlled trial.

Wells R, Stockdill M, Dionne-Odom J, Ejem D, Burgio K, Durant R Trials. 2018; 19(1):422.

PMID: 30081933 PMC: 6090835. DOI: 10.1186/s13063-018-2770-9.


Differences in do-not-resuscitate orders, hospice care utilization, and late referral to hospice care between cancer and non-cancer decedents in a tertiary Hospital in Taiwan between 2010 and 2015: a hospital-based observational study.

Shih T, Chang H, Lin M, Chen C, Chen T, Hwang S BMC Palliat Care. 2018; 17(1):18.

PMID: 29368644 PMC: 5784719. DOI: 10.1186/s12904-018-0271-y.


An integrated review of interventions to improve psychological outcomes in caregivers of patients with heart failure.

Evangelista L, Stromberg A, Dionne-Odom J Curr Opin Support Palliat Care. 2015; 10(1):24-31.

PMID: 26716392 PMC: 4760617. DOI: 10.1097/SPC.0000000000000182.